Chakraborty (1).jpg

Payal Chakraborty

Postdoctoral Research Fellow, Harvard Medical School
Chapter Member: Boston SSN
Areas of Expertise:

Connect with Payal

About Payal

Chakraborty's research focuses on sexual and reproductive health. Overarching themes in Chakraborty's writings include a focus on reproductive autonomy through ensuring that individuals have the resources, support, and agency to enact their reproductive health choices, with a specific emphasis on impacts of existing structures and policies, as well as proposed legislation, on sexual and reproductive health outcomes. Chakraborty is a Graduate Research Associate with the Ohio Policy Evaluation Network, and is Treasurer of the Public Health Graduate Student Association.

Contributions

In the News

Quoted by Mary Schuermann Kuhlman in "Ohio Research: Post-Roe Scenario Would Increase Travel for Abortion Care," Public News Service, May 14, 2022.

Publications

"Passage of Abortion Ban and Women’s Accurate Understanding of Abortion Legality." (with Alison Norris, Danielle Bessett, Maria F. Gallo, John B. Casterline, and Abigail Norris Turner). American Journal Obstetrics and Gynecology 225, no. 1 (2021): 63.

Discusses how among reproductive-aged women in Ohio, legislative and judicial activities around Ohio's 6-week abortion ban was associated with increased percentages of women believing abortion to be illegal. Clarifies that Ohio lawmaker's attempts to restrict abortion in the state could lead to women believing that abortion is illegal, even when when unsuccessful.

"Abortion Travel Within the United States: An Observational Study of Cross-State Movement To Obtain Abortion Care in 2017" (with Danielle Bessett, Zoe Muzyczka, Elaina Johns-Wolf, and Jenny Higgins). The Lancet Regional Health 10 (2022).

Mentions in the US in 2017, an average of 8% of patients left their state of residence to access abortion care. Shows state-level abortion policy and scarcity of abortion facilities are associated with cross-state travel to obtain abortion care.

"Abortion Access in Ohio’s Changing Legislative Context, 2010–2018" (with Danielle Bessett, Alison H. Norris, Kaiting Lang, Robert B. Hood, Sarah R. Hayford, and Lisa Keder). American Journal of Public Health (2020).

Examines abortion utilization in Ohio from 2010 to 2018 when about 15 laws restricting abortion went into effect. Reveals abortion policies co-occur with later abortions, suggesting delays to abortion care. Restrictive policies also increase geographic inequities, especially in rural areas.

"Use of Nonpreferred Contraceptive Methods Among Women in Ohio" (with Maria F. Gallo, Alison H. Norris, John Casterline, and Abigail Norris Turner). Contraception Journal 103, no. 5 (2021): 326-335.

Establishes about a quarter of adult reporductive aged women in Ohio reported not using their preferred contraceptive method in 2018–2019. Mentions affordability and poor provider satisfaction related to contraceptive care were associated with not using one's preferred contraceptive method.

"How Ohio’s Proposed Abortion Bans Would Impact Travel Distance To Access Abortion Care" (with Danielle Bessett, Stef Murawsky, Mikaela H. Smith, Michelle L. McGowan, and Alison H. Norris). Perspectives on Sexual and Reproductive Health (2022).

Studies how travel distance to abortion care would be impacted if any of three of Ohio's proposed abortion bans go into effect in a post-Roe context. Stresses distance for Ohioans would increase dramatically from an average of 26 miles as of February 2022 to 157 miles in a best case post-Roe scenario or 269 miles in a worst-case scenario.

"Federal, State, and Institutional Barriers to the Expansion of Medication and Telemedicine Abortion Services in Ohio, Kentucky, and West Virginia During the COVID-19 Pandemic." (with Danielle Bessett, Kelsey Mello, Mikaela H. Smith, B. Jessie Hill, Alison H. Norris, and Michelle L. McGowan). Contraception Journal 103, no. 5 (2021): 111-116.

Shows the REMS on mifepristone is a barrier to expansion of medication and telemedicine abortion services in OH, KY, and WV, but lifting of the REMS alone would not expand access to medication abortion because of other state restrictions.